NuGen M.D. signs $333,000 distribution deal with Intermediq for InsuJet in Sri Lanka

NuGen Medical Devices entered into an exclusive distribution agreement with Intermediq Holdings for its InsuJet needle-free injection device in Sri Lanka, valued at a minimum of CAD$333,000 over five years, starting upon regulatory approval expected in H2 2022.

“We are very pleased to have partnered with Intermediq to provide access to our InsuJet needleless injection devices to improve the lives of those suffering from chronic illnesses in Sri Lanka.”nugenmd.com

• 1 source
• nugenmd.comNuGen M.D. Announces a $333,000 5-Year Distribution AgreementChris BrownJan 18, 2022

Summarized from public sources; check the original articles before acting on it.